Tandem Diabetes Care, Inc. has entered into a definitive agreement to acquire AMF Medical SA, the privately held Swiss developer of the Sigi™ Patch Pump.
BIOCORP has announced that they have received 510(K) clearance from the U.S. Food & Drug Administration (FDA) to market Mallya, its smart sensor that is
Novo Nordisk has announced that UK users of the Abbott FreeStyle LibreLink app can now connect to its smart insulin pens. People living with diabetes
Eli Lilly has pulled out of a partnership with Ypsomed that would have given it a branded insulin pump to sell in the U.S. Lilly
A recent trial has linked Abbott’s FreeStyle Libre 2 continuous glucose monitor (CGM) to significantly lower blood sugar levels than fingerstick testing. The study, published
All 130,000 Australians with Type 1 diabetes will now get access to subsidised continuous glucose monitoring (CGM) devices under the newly-elected Australian Prime Minister Anthony
The French pharmaceutical giant Sanofi has agreed to pay digital health company Dario Health $30 million to market its diabetes products. In return, Dario Health
A team led by mechanical engineers from the Massachusetts Institute of Technology (MIT) in America has patented two new devices to reduce the rigmarole of
Tandem Diabetes Care has announced that it expects to treble its worldwide customer base to one million people within the next five years, mainly by
Medtronic one of the world’s leading medical device companies, has been hit by a warning letter from the regulatory Food and Drug Administration (FDA) in
